clinical trial tirzepatide cardiovascular outcomes results july 2025 Reduction of prevalence of patients meeting the criteria for Tirzepatide: A Systematic Update

La evidencia reciente ha demostrado beneficios teraputicos en: eventos cardiovasculares mayores, insuficiencia cardaca con fraccin de eyeccin preservada, prevencin de diabetes, apnea obstructiva del sueo, enfermedad arterial perifrica, enfermedad renal crnica y esteatohepatitis asociada a disfuncin metablica (MASH)

The compound did exactly what it was designed to do: selectively promote lipolysis without systemic side effects

It's how I built Modern Thyroid Clinic

Most of the survey respondents (90%) had been prescribed GLP-1 medication for weight loss, while 24% said that the medication was prescribed to treat PCOS (respondents were allowed to select more than one answer here)